Skip to main content
Glama

Nato

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.4/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already cover readOnly/openWorld/idempotent/non-destructive safety, so the bar is for added context; the description adds meaningful behavioral detail: graceful degradation (LEI/FIGI enrichment degrades, EDGAR identifiers still return), internal cascading through multiple endpoints, and the explicit rule about passing the entity name only rather than the full noun phrase. It does not document pagination or exact response shape, but with no output schema that is a minor gap.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is information-dense but long and somewhat sprawling, with parenthetical-heavy nesting that makes it harder to scan. The most important guidance is front-loaded, but the LEI/FIGI detail in the middle is lengthy, and a few clauses ('more than one instrument' / 'exact ticker map when a ticker is implied') are muddled and could be tightened.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a two-parameter tool with 100% schema coverage and no output schema, the description covers what input goes in, what identifiers come back, how failures degrade, and the main pitfall (passing the full noun phrase). It does not describe the return shape or mention the `unresolved` field referenced in the description, but overall it is close to complete for the tool's complexity.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description adds substantial value beyond the schema: it explains how value is interpreted per type, gives concrete formats (AAPL, CIK 0000320193, ISIN example), and details the 'entity name only' constraint and why. This elevates it above the baseline.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a precise verb-resource pairing ('resolve a user-spoken NAME to the canonical/official identifiers other tools require as input'), gives concrete example queries, enumerates supported entity types, and is clearly differentiated from siblings like compare_entities or entity_profile. The opening spoken-language examples make the tool's purpose instantly recognizable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'Use FIRST whenever you have a name but need an ID,' and the description emphasizes it replaces 2-3 manual lookups. It distinguishes supported types and clearly states that non-equity instruments without tickers DO resolve here, which prevents an agent from wrongly assuming it is equity-only.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Nato toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.1/5.0
Disambiguation2/5

Multiple tools blur together: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-variants, and the six polymarket_* tools plus bet_research heavily overlap in purpose. Descriptions are detailed and cross-reference each other, but an agent must read very long definitions to avoid misselection.

Naming Consistency4/5

The set is consistently snake_case with helpful domain prefixes like ask_pipeworx, polymarket_*, and scan_*. Deviations such as deep_research, entity_profile, recent_alerts, and the bare verbs remember/recall/forget break a strict verb_noun pattern but remain predictable.

Tool Count3/5

34 tools is heavy for one server, and several groups could plausibly be consolidated. However, the platform spans data lookup, research, prediction markets, memory, subscriptions, and utilities, so the breadth partially justifies the count.

Completeness5/5

The surface covers lookup, grounded verification, deep research, entity comparison, claim validation, prediction-market analysis, memory CRUD, subscription lifecycle, and discovery. There are no obvious dead ends, and gaps are minor or workaroundable.

Resources